Integra LifeSciences to Present At Citi Investment Research Health Care Conference

Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it
is to present at the 2008 Citi Investment Research Health Care Conference at the
Hilton New York in New York City on May 22nd at 2:00 PM.

Integra LifeSciences Holdings Corporation, a world leader in regenerative
medicine, is dedicated to improving the quality of life for patients through the
development, manufacturing, and marketing of cost-effective surgical implants
and medical instruments. Our products, used primarily in neurosurgery, extremity
reconstruction, orthopedics and general surgery, are used to treat millions of
patients every year. Integra's headquarters are in Plainsboro, New Jersey, and
we have research and manufacturing facilities throughout the world. Please visit
our website at (http://www.Integra-LS.com).

Statements made at the upcoming conferences may be forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve risks and uncertainties that could cause
actual results to differ from predicted results. Forward-looking factors that
may be discussed include, but are not limited to, future financial performance,
new product development, governmental approvals, market potential and resulting
sales as well as potential therapeutic applications, and additional
acquisitions. These risks and uncertainties include market conditions and other
factors beyond the Company's control and the economic, competitive,
governmental, technological and other factors identified under the heading "Risk
Factors" included in item IA of Integra's Annual Report on Form 10-K for the
year ended December 31, 2007 and information contained in subsequent filings
with the Securities and Exchange Commission could affect actual results.

IART-G

-0-
CONTACT: Integra LifeSciences Holdings Corporation
John B. Henneman, III, Executive Vice President Finance
and Administration, Chief Financial Officer
(609) 936-2481
jhenneman@Integra-LS.com
Karen Mroz-Bremner, Senior Manager, Corporate Development
and Investor Relations
(609) 936-6929
karen.mroz-bremner@integra-LS.com